MPM BioImpact LLC - EPIZYME INC ownership

Quarter-by-quarter ownership
MPM BioImpact LLC ownership history of EPIZYME INC
ValueSharesWeighting
Q2 2022$5,035,000
+27.8%
3,425,2020.0%1.40%
+32.4%
Q1 2022$3,939,000
-54.0%
3,425,2020.0%1.06%
-32.3%
Q4 2021$8,563,000
-57.9%
3,425,202
-13.8%
1.56%
-50.5%
Q3 2021$20,341,000
+5.0%
3,972,830
+70.4%
3.16%
-0.9%
Q2 2021$19,375,000
-4.6%
2,331,5340.0%3.18%
+24.7%
Q1 2021$20,308,000
-63.9%
2,331,534
-55.0%
2.55%
-47.5%
Q4 2020$56,322,000
+65.4%
5,186,271
+81.7%
4.86%
-40.7%
Q3 2020$34,057,000
-9.0%
2,854,737
+22.4%
8.20%
-17.6%
Q2 2020$37,444,000
+3.5%
2,331,5340.0%9.96%
-54.9%
Q1 2020$36,162,000
-37.0%
2,331,5340.0%22.09%
+8.7%
Q4 2019$57,356,0002,331,53420.33%
Other shareholders
EPIZYME INC shareholders Q3 2023
NameSharesValueWeighting ↓
RP Management, LLC 9,166,667$109,358,00016.39%
Burrage Capital Management LLC 1,002,528$11,960,0009.44%
Foresite Capital Management III, LLC 998,278$11,909,0008.87%
MPM BioImpact LLC 2,854,737$34,057,0008.20%
Palo Alto Investors LP 6,403,600$76,395,0004.19%
Foresite Capital Management II, LLC 862,402$10,288,0002.24%
Redmile Group, LLC 8,311,633$99,158,0001.82%
Pier Capital, LLC 574,299$6,851,0001.00%
Foresite Capital Management I, LLC 243,759$2,908,0000.82%
Rock Springs Capital Management LP 2,551,659$30,441,0000.77%
View complete list of EPIZYME INC shareholders